对心房的临床遗传检测:我们还在那里吗?
Jason D Roberts1, Brandon Chalazan2, Jason G Andrade3
1Population Health Research Institute, McMaster University, and Hamilton Health Sciences, Hamilton, Ontario, Canada.
The Canadian journal of cardiology
|March 29, 2024
概括
遗传因素在心房动 (AF) 中起作用. 早期发作的AF的遗传检测可以确定危及生命的疾病的风险,指导未来的治疗.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 心房动 (AF) 的遗传是复杂的,多基因因素是最常见的.
- 罕见的变异与有限数量的AF病例有关.
- 早期发作的AF可能是潜在心肌病或通道病的迹象.
研究的目的:
- 审查与AF相关的遗传因素.
- 讨论目前对早期发作的AF进行遗传测试的实用性.
- 探索在AF管理中基因测试的未来潜力.
主要方法:
- 在AF的遗传研究的文献综述.
- 对早期发作的AF遗传检测当前临床方法的分析.
- 讨论AF的遗传基质的新兴研究.
主要成果:
- 鉴定与AF相关的特定基因中的罕见变异.
- 认识到早期发作的AF可能会出现潜在的恶性心脏病.
- 在早期发病的AF患者中,致病性罕见变体与增加的死亡风险之间的关联.
结论:
- 在早期发病的AF中,基因检测可能会揭示严重心脏病的风险.
- 遗传洞察力可以改善患者对治疗的选择,并指导新的治疗开发.
- 需要进一步的研究,以整合基因检测普遍用于早期发病的AF.
更多相关视频
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
11.0K
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
1.7K
相关概念视频
Karyotyping
Overview
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
